Nifty Pharma Today: Index Gains 0.15% to 28,200.50
- September 7, 2026
- Posted by: Harsh Piplani
- Category: News
Nifty Pharma today ended marginally higher on 18 November 2026, emerging as the strongest sector index in the session. The index finished at 28,200.50, up 43.40 points or 0.15%, while gains in select pharma shares offset declines elsewhere in the basket.
Quick sector takeaways
- Nifty Pharma rose 0.15% to close at 28,200.50, compared with the previous close of 28,157.10.
- The index moved between 28,132.20 and 28,436.65 during the session, before ending close to its opening level of 28,201.55.
- Breadth was evenly balanced, with 10 advancing stocks and 10 declining stocks across the index.
- Cipla, Glenmark Pharmaceuticals and Lupin led the percentage gainers, while JB Chemicals & Pharmaceuticals and Granules India were among the notable decliners. Watch whether the index can sustain trade around 28,200.50 next session.
Nifty Pharma today: a modest lead among sector indices
Nifty Pharma today delivered a restrained but positive end-of-session performance. The 43.40-point advance from the previous close translated into a 0.15% gain, placing the pharma gauge at the top of the sector-index ranking for the day.
The closing position nevertheless reflected a mixed underlying session rather than a broad one-way move. The index opened at 28,201.55, climbed to 28,436.65, and later settled at 28,200.50. That left it marginally below its opening mark but above the previous close, highlighting intraday variation within an otherwise modest positive finish.
Prices referenced in this update were recorded at 4:15:00 PM IST on 18 November 2026. For a broader session dashboard, visit Univest Market View.
Price snapshot
| Metric | Level | Session reading |
|---|---|---|
| Close | 28,200.50 | Up 43.40 points |
| Previous close | 28,157.10 | Base for the day’s change |
| Day high | 28,436.65 | Highest intraday level |
| Day low | 28,132.20 | Lowest intraday level |
The day’s range was 304.45 points from low to high. The close stood 236.15 points below the high and 68.30 points above the low. These levels describe the session’s trading range and provide useful reference points for following the next day’s price action.
Sector ranking
Nifty Pharma was the top gaining sector index because it was the only index in this comparison to end in positive territory. The full ranking, from the strongest gain to the steepest fall, was: Nifty Pharma up 0.15%, Nifty FMCG down 0.09%, Nifty Bank down 0.38%, Nifty Financial Services down 0.72%, Nifty IT down 1.24%, Nifty Auto down 1.35%, Nifty Mid Select down 1.36%, and Nifty Metal down 2.46%.
This ranking places pharma at the relative forefront of the day’s sector performance, although its advance was measured. The gap between pharma’s positive close and the declines recorded by the other listed indices was the key feature of the session-level comparison.
Constituent breadth
Market breadth within Nifty Pharma was exactly balanced: 10 stocks advanced and 10 declined, with no stocks unchanged. An advance-decline split of one to one indicates that the index’s positive finish came amid an even division between gaining and falling shares.
That balance matters because an index can rise even when participation is mixed. Here, the positive moves in several stocks were enough to leave the sector gauge higher by the close, while declines in other names kept the overall gain contained.
Heavyweights versus broader participation
The larger stocks in the index offered a mixed picture. Sun Pharmaceutical Industries gained 0.08% to ₹1,871.50, while Cipla rose 2.09% to ₹1,417.00 and Dr. Reddy’s Laboratories added 0.73% to ₹1,398.20. In contrast, Divi’s Laboratories declined 0.91% to ₹11,049.00 and Torrent Pharmaceuticals fell 1.24% to ₹4,610.70.
The same group featured prominently among the session’s closely followed names, underscoring the contrasting moves among major pharma stocks. Cipla’s stronger rise stood alongside declines in Divi’s Laboratories and Torrent Pharmaceuticals, consistent with the index’s balanced breadth reading.
Key Nifty Pharma stocks
| Stock | Move | Why it matters |
|---|---|---|
| Cipla | +2.09% to ₹1,417.00 | It was the leading percentage gainer among the highlighted stocks. |
| Glenmark Pharmaceuticals | +1.16% to ₹2,646.10 | Its gain supported the positive side of the sector’s breadth. |
| Lupin | +1.12% to ₹1,971.90 | It closed higher after trading between ₹1,946.20 and ₹1,993.00. |
| JB Chemicals & Pharmaceuticals | -3.87% to ₹2,408.90 | It was the steepest percentage decliner in the index. |
| Granules India | -2.21% to ₹797.50 | Its decline was among the more pronounced negative moves. |
Biggest positive movers
Cipla led the gainers with a 2.09% rise to ₹1,417.00 after touching an intraday high of ₹1,435.00. Glenmark Pharmaceuticals advanced 1.16% to ₹2,646.10, Lupin added 1.12% to ₹1,971.90, and Ipca Laboratories rose 1.07% to ₹1,854.10. Alkem Laboratories completed the leading group with a 0.92% gain to ₹5,222.50.
These gains show where the day’s positive price action was concentrated. Cipla’s move was the strongest among the five, while the other four names recorded gains ranging from 0.92% to 1.16%.
Biggest negative movers
JB Chemicals & Pharmaceuticals declined 3.87% to ₹2,408.90, after trading as low as ₹2,380.00. Granules India fell 2.21% to ₹797.50. Abbott India lost 1.34% to ₹25,470.00, Torrent Pharmaceuticals slipped 1.24% to ₹4,610.70, and Ajanta Pharma declined 1.17% to ₹3,273.80.
The scale of these declines explains why the sector’s overall rise remained limited despite multiple stocks ending higher. The session therefore showed clear stock-specific divergence within the pharma space.
Stocks to watch next session
- Cipla: It closed at ₹1,417.00 after a 2.09% rise and an intraday high of ₹1,435.00.
- Glenmark Pharmaceuticals: It ended 1.16% higher at ₹2,646.10.
- Lupin: It gained 1.12% to ₹1,971.90.
- JB Chemicals & Pharmaceuticals: It ended at ₹2,408.90 after the session’s sharpest percentage fall.
- Divi’s Laboratories: It closed at its day low of ₹11,049.00, down 0.91%.
- Torrent Pharmaceuticals: It finished at ₹4,610.70, also its day low, down 1.24%.
The constructive case
The constructive evidence is straightforward: Nifty Pharma closed higher by 0.15% and ranked first among the listed sector indices. Cipla, Glenmark Pharmaceuticals, Lupin, Ipca Laboratories and Alkem Laboratories posted gains, while the index retained a close above the previous day’s 28,157.10 level.
The index also finished 68.30 points above its intraday low. Combined with 10 advancing stocks, that provides a factual basis for the sector’s modestly positive closing reading.
The cautious case
The cautious case rests on the even breadth and the intraday retreat from 28,436.65. Ten stocks declined, including notable falls in JB Chemicals & Pharmaceuticals, Granules India, Abbott India and Torrent Pharmaceuticals. The close at 28,200.50 was also nearly unchanged from the 28,201.55 opening level.
This combination points to a divided session rather than uniform strength across pharma shares. The next session’s behaviour in the leading gainers and decliners will help show whether the positive index close broadens or remains narrowly distributed.
Univest Insights
The main takeaway from nifty pharma today is relative resilience. A 0.15% gain may appear small in isolation, but it stood out against declines in every other sector index in the comparison.
At the same time, breadth was neutral rather than decisively positive. With 10 gainers and 10 losers, the session was defined by offsetting stock moves, not a broad sector-wide advance.
Cipla’s 2.09% gain was the clearest positive move among the highlighted shares, while JB Chemicals & Pharmaceuticals’ 3.87% drop was the largest decline. Those opposing moves capture the dispersion that shaped the sector’s close.
For the next session, monitor whether Nifty Pharma holds above 28,157.10 and whether breadth moves away from the even 10-10 split.
Published on 18 November 2026 at 4:15 PM IST
Know more with Univest
Log in to Univest to explore market insights, track stocks, and get 3 free trade ideas on Share Market Today.
Frequently asked questions
How did Nifty Pharma close today?
Nifty Pharma closed at 28,200.50 on 18 November 2026, up 43.40 points or 0.15% from 28,157.10.
What was Nifty Pharma’s intraday range today?
The index traded between a low of 28,132.20 and a high of 28,436.65.
Why was Nifty Pharma the top gaining sector index?
Nifty Pharma rose 0.15%, while every other sector index in the comparison ended lower for the session.
What was the breadth in Nifty Pharma stocks?
Ten stocks advanced and 10 declined, with no stocks unchanged.
Which stocks gained the most in Nifty Pharma today?
Cipla gained 2.09%, followed by Glenmark Pharmaceuticals at 1.16%, Lupin at 1.12%, Ipca Laboratories at 1.07% and Alkem Laboratories at 0.92%.
Which stocks declined the most in Nifty Pharma today?
JB Chemicals & Pharmaceuticals fell 3.87%, Granules India declined 2.21%, and Abbott India lost 1.34%.
Disclaimer
Investments in securities markets are subject to market risks. Read all related documents carefully before investing. This sector-index update is for informational and educational purposes only and is not personalized investment advice or a recommendation to buy, sell, or hold any security.